“Whether and How the U.S. Government Should Exercise Its Compulsory Licensing Authority Under 28 U.S.C. § 1498 and the Bayh-Dole Act”

  • Intellectual Property and Antitrust
New York University Journal of Intellectual Property and Entertainment Law
2021

“Anticommons, Transaction Costs, and Patent Aggregators”

  • Intellectual Property and Antitrust
Research Handbook on the Economics of Intellectual Property Law
2019

“Cannabis for Medical Use: FDA and DEA Regulation in the Hall of Mirrors”

  • Health Law
Food and Drug Law Journal
2019

“A Functional Approach to Judicial Review of PTAB Rulings on Mixed Questions of Law and Fact”

  • Intellectual Property and Antitrust
Iowa Law Review
2019

“Opting Into Device Regulation in the Face of Uncertain Patentability”

  • Intellectual Property and Antitrust
  • Law and Technology
Marquette Intellectual Property Law Review
2019

“Intellectual Property and Public Health”

  • Intellectual Property and Antitrust
  • Health Law
Oxford Handbook of Intellectual Property Law
2018

“Promoting Healthcare Innovation on the Demand Side”

  • Intellectual Property and Antitrust
  • Law and Technology
Journal of Law and the Biosciences
2017

“Insurance for broad genomic tests in oncology”

  • Health Law
Science
2017

“Diagnostics Need Not Apply”

  • Intellectual Property and Antitrust
  • Law and Technology
Boston University Journal of Science & Technology Law
2015

“Patents and Regulatory Exclusivity in the USA”

Encyclopedia of Health Economics
2014

“Wisdom of the Ages or Dead-Hand Control? Patentable Subject Matter for Diagnostic Methods After In Re Bilski”

  • Intellectual Property and Antitrust
Case Western Reserve Journal of Law, Technology & the Internet
2012

“Data Secrecy in the Age of Regulatory Exclusivity”

  • Intellectual Property and Antitrust
The Law and Theory of Trade Secrecy: A Handbook of Contemporary Research
2011

“Patent Costs and Unlicensed Use of Patented Inventions”

  • Intellectual Property and Antitrust
University of Chicago Law Review
2011

“Costs, Norms, and Inertia: Avoiding an Anticommons for Proprietary Research Tools”

  • Intellectual Property and Antitrust
Working Within the Boundaries of Intellectual Property: Innovation Policy for the Knowledge Society
2010